Medicare Enrolled

Dr. Sandeep Gupta, M.D.

Allergy Physician · Dallas, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
8220 WALNUT HILL LN, Dallas, TX 75231
2143691901
Registered in NPPES since 2006
NPI: 1336193069 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gupta from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gupta? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gupta

Dr. Sandeep Gupta is an allergy physician in Dallas, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Gupta performed 2,058 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Gupta received a total of $8,829 from 36 pharmaceutical and/or device companies across 324 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gupta is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ 2,058 Medicare services $8,829 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
2,058
Medicare services
Bottom 30% in TX for allergy physician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$23
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Injection, mepolizumab, 1 mg 1,800 $23 $35
Allergy injection therapy, multiple injections
A professional service involving the administration of multiple allergen injections.
82 $8 $25
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
41 $10 $40
Expiratory airflow and volume test
A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume.
30 $19 $55
Nitric oxide gas level test
A test that measures the level of nitric oxide gas in the body.
28 $14 $30
Allergen injection administration
Professional service for the administration of a single allergen injection.
21 $5 $20
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
20 $89 $140
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
19 $60 $100
Health risk assessment administration and interpretation
This procedure involves administering a health risk assessment to a patient and interpreting the results.
17 $2 $8
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$8,829
Total received (2018-2024)
Avg $1,261/year across 7 years
Top 21% in TX for allergy physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
324
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,238
2023
$1,558
2022
$1,028
2021
$928
2020
$707
2019
$2,878
2018
$493

Payments by company (2024)

AstraZeneca Pharmaceuticals LP
$232
Grifols USA, LLC
$197
Regeneron Healthcare Solutions, Inc.
$194
GENZYME CORPORATION
$117
GlaxoSmithKline, LLC.
$82
Pharming Healthcare, Inc.
$81
Amgen Inc.
$76
BioCryst US Sales Co., LLC
$57
Janssen Pharmaceuticals, Inc
$31
ADMA BioManufacturing LLC
$27
Greer Laboratories, Inc.
$26
Actelion Pharmaceuticals US, Inc.
$22
Blueprint Medicines Corporation
$21
Novartis Pharmaceuticals Corporation
$20
HOSPIRA, INC.
$19
Genentech USA, Inc.
$19
Optinose US, Inc.
$18
Top 3 companies account for 50.3% of 2024 payments
All-time payments by company (2018-2024) ›
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,906
GlaxoSmithKline, LLC.
$987
AstraZeneca Pharmaceuticals LP
$787
Regeneron Healthcare Solutions, Inc.
$646
Janssen Pharmaceuticals, Inc
$606
GENZYME CORPORATION
$489
Grifols USA, LLC
$436
Takeda Pharmaceuticals U.S.A., Inc.
$400
Abbott Laboratories
$350
Pharming Healthcare, Inc.
$253
Genentech USA, Inc.
$243
Teva Pharmaceuticals USA, Inc.
$204
Actelion Pharmaceuticals US, Inc.
$203
Amgen Inc.
$181
BioCryst US Sales Co., LLC
$149
Novartis Pharmaceuticals Corporation
$143
Shire North American Group Inc
$114
CSL Behring
$80
Covis Pharma GmBH
$65
ALK-Abello, Inc
$65
PFIZER INC.
$65
OptiNose US, Inc.
$60
Optinose US, Inc.
$48
Octapharma USA, Inc.
$41
BioCryst Pharmaceuticals, Inc.
$40
Blueprint Medicines Corporation
$39
Mylan Specialty L.P.
$37
Philips Electronics North America Corporation
$27
ADMA BioManufacturing LLC
$27
Xoran Technologies
$27
Greer Laboratories, Inc.
$26
Merck Sharp & Dohme LLC
$20
HOSPIRA, INC.
$19
Covis Pharma B.V.
$17
BOSTON SCIENTIFIC CORPORATION
$16
Merck Sharp & Dohme Corporation
$16
Top 3 companies account for 41.7% of all-time payments
Associated products mentioned in payments ›
AIRSUPRA · ALAIR · ALVESCO · ANORO · AYVAKIT · BREO · BREZTRI · CINQAIR · CUTAQUIG · CUVITRU · DUPIXENT · ENSITE · EUCRISA · FASENRA · Gamunex-C · HYQVIA · Haegarda · Hizentra · MiniCAT · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT · ORLADEYO · Odactra · Orladeyo · PANZYGA · Palforzia · ProAir Digihaler · QVAR · RUCONEST · Respiratoriy Care Undiv · STANDARDIZED · STIOLTO RESPIMAT · SYMBICORT · TAKHZYRO · TEZSPIRE · TIMOTHY · TRELEGY ELLIPTA · UPTRAVI · XARELTO · XOLAIR · Xembify · Xhance · Xolair · Yupelri
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an allergy physician in Dallas?
Compare allergy physicians in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse allergy physicians nearby

Geographic Context

Allergy physicians in nearby ZIP areas
13
County median income
$74,149
Nearest hospital to ZIP centroid (approximate)
TEXAS HEALTH PRESBYTERIAN HOSPITAL DALLAS
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Gupta is a mixed practice specialist, with moderate Medicare volume, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Gupta experienced with injection, mepolizumab, 1 mg?
Based on Medicare claims data, Dr. Gupta performed 1,800 injection, mepolizumab, 1 mg services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Gupta receive payments from pharmaceutical companies?
Yes. Dr. Gupta received a total of $8,829 from 36 companies across 324 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gupta's costs compare to other allergy physicians in Dallas?
Dr. Gupta's average Medicare payment per service is $23. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gupta) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →